Postherpetic Neuralgia

A Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Postherpetic Neuralgia (RELIEFPHN1) (Post Shingles Pain).

Study Information

Condition

Postherpetic Neuralgia

Phase II

Conquest Research needs volunteers for an investigational trial evaluating a medication designed to help treat patients suffering from Postherpetic Neuralgia. You may qualify if you:

  • Are at least 18 years of age

  • Presence of pain after the healing of shingles

Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

Sign Up For A Study

What To Expect

PATIENT RESOURCES & FAQ

Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

SEE MORE
A mature medical doctor smiling as some of his colleagues stand in the background

Register For A Study!

Register